NIH paused Eli Lilly Covid-19 antibody trial because of safety concerns
Lilly had reported its antibody reduced the amount of virus in patients’ nasal swabs and may have kept some patients out of the hospital.
It will be two weeks until there is news on a paused trial of Eli Lilly’s closely watched monoclonal antibody to treat Covid-19.
“one of the two groups in the study — one had received the antibody, the other a placebo — was doing better than the other”
If you missed yesterday afternoon's news: One trial for Lilly's Covid-19 antibody treatment has been paused for at least two weeks.
summarize what that pause could mean
13/ On monoclonals: they will probably represent an advance, though not a “miracle cure.” Yesterday, Lilly (
) put its monoclonal trial on hold to investigate possible side effect; not clear what this means